Guillain-Barre Syndrome consists of a group of neuropathic conditions characterized by progressive weakness and diminished or absent myotatic reflexes.
Skelton, Tyler B
core
Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report. [PDF]
Hughes CL, Yorio JT, Kovitz C, Oki Y.
europepmc +1 more source
Guillain-Barré Syndrome Associated with SARS-CoV-2 in Two Pediatric Patients. [PDF]
Al Amrani F +4 more
europepmc +1 more source
Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis. [PDF]
ElSawi HA, Elborollosy A.
europepmc +1 more source
FDA and CDC issue alert on Menactra meningococcal vaccine and Guillain Barre Syndrome [PDF]
Friday, September 30, 2005, 19:00 EDT (7:00 PM EDT)CDCHAN-00237-2005-09-30-ADV-NThe Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are alerting consumers and health care providers to five reports of Guillain Barre
core
Recurrent Guillian Barre’ Syndrome vs acute onset CIDP - study of 2 cases.
The most common acquired immune mediated polyneuropathies are acute inflammatory demyelinating polyradiculoneuropathy(AIDP), a form of Gullian Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy(CIDP).
Dhamne, Megha Chetan, Mohan, Sankalp
core +1 more source
MRI Features of Multiple Cranial Neuropathies in Guillain-Barré Syndrome Occurring after COVID-19 Vaccination: A Case Report. [PDF]
Soh Y, Yoo EA, Kim ES, Kim SJ.
europepmc +1 more source
Guillain-Barre syndrome as the initial presentation of systemic lupus erythematosus: Case report with a systematic and literature review. [PDF]
Bhoi SK, Jha M, Jaiswal B.
europepmc +1 more source
Tuberculosis and Guillian Barre Syndrome – A Rare Presentation of AMAN Variant
openaire +1 more source

